Researchers compared online prescribing and traditional physician consultation for treating erectile dysfunction, finding that the online system outperformed in patient education and prescription appropriateness. The study concludes that a well-regulated Internet prescriber service can be comparable to traditional medical practice.
Researchers found that white patients with two distinct gene variations were more likely to experience remission of symptoms associated with major depression. Pharmacogenetic testing could improve patient outcomes by matching patients with the right drug from the start.
Researchers have found a gene mutation linked to one family's hereditary form of atrial fibrillation, leading to better understanding and potential new treatments. The discovery provides insight into pathways that may be applicable to people in the general population with atrial fibrillation.
Researchers found a significant reduction in LDL cholesterol and triglycerides in patients taking fish oil and red yeast rice supplements. The study suggests a comprehensive approach to lipid lowering could be effective for patients unwilling or unable to take statins.
A new implantable device blocks stomach nerve signals, resulting in significant weight loss in obese participants. The study found that a quarter of patients lost over 25% of their excess weight and three patients lost more than 30%. A follow-up double-blinded study will be conducted to assess the device's true effectiveness.
Researchers found that the measles virus can replicate only in immune cells, causing disease in monkeys and potentially improving cancer therapy efficacy. The study's findings challenge traditional textbook assumptions about how the virus spreads, paving the way for more effective vaccines and treatments.
Research by Mayo Clinic found that people with lower incomes and education levels are more likely to die after a heart attack. The study analyzed data from 705 patients treated for heart attack between 2002 and 2006, showing survival rates were lowest for those with the lowest income and education.
A recent Mayo Clinic study found that rural, unmarried women have lower self-rated health status and are more prone to depression compared to their married counterparts. The study suggests that primary care physicians should take a proactive role in addressing health concerns of single women.
Gamma-secretase modulators, a class of agents in testing to treat Alzheimer's, work by reducing long Abeta peptides and increasing shorter ones that inhibit aggregation. This could lead to new treatments for the disease, with one such drug, tarenflurbil, showing promise in patients with mild Alzheimer's.
Researchers at Mayo Clinic found that heart patients who met regularly with cardiac 'disease managers' for three years had better control of risk factors and lower death rates. The approach demonstrated clear clinical benefits, including improved cholesterol levels, blood pressure, and medication compliance.
Scientists have identified p16 as a gene that accelerates cellular aging, while p19 slows it down. The study sheds light on the development of aging-related characteristics such as loss of muscle mass and cataracts.
Researchers found that prucalopride significantly improved bowel movements and quality of life for patients with severe chronic constipation. The study involved 620 patients who received either prucalopride or a placebo, showing that nearly half took notice in their bowel movements per week.
Researchers found that carrying alpha-1 antitrypsin deficiency increases lung cancer risk in smokers and nonsmokers, with the genetic disorder explaining up to 12% of lung cancer patients. Individuals who carry the gene should be screened for lung cancer and avoid potential carcinogens.
Researchers at Mayo Clinic have developed a high-resolution confocal endomicroscopy probe system that can accurately identify benign colon polyps without removal. The technology was tested in 37 patients and showed an accuracy rate of 98% in flagging non-cancerous polyps.
The study found that Mayo Clinic's intensive care unit (ICU) pneumonia prevention rate is similar to the national average, but lower for trauma ICUs. The most common pathogen causing VAP was Pseudomonas aeruginosa, highlighting the need for targeted antibiotic treatment.
Researchers at Mayo Clinic have developed a computer-based simulation program, CASPER, to help patients with asthma manage their disease. The program allows patients to practice making key decisions in a safe, simulated environment, improving their ability to consistently treat their asthma.
A new study suggests that the depth of cancer penetration in the bowel wall affects survival rates, and proposes changes to current guidelines. Patients with thin lesions confined to the bowel wall have better survival outcomes than those with thicker cancers.
Researchers at Mayo Clinic found a correlation between women who underwent pre-surgical breast MRI and an increased rate of mastectomy. The study suggests that MRI may lead to greater anxiety, prompting patients and physicians to choose mastectomy over lumpectomy.
A study presented at the American Society of Clinical Oncology annual meeting found that adding epratuzumab to standard chemotherapy (R-CHOP) resulted in a 95% response rate and 63% disease-free survival in patients with diffuse large B-cell lymphoma. The treatment was well-tolerated, but final results will be reported next year.
A study by Mayo Clinic researchers found that administering calcium and magnesium before and after oxaliplatin chemotherapy significantly reduces neurological side effects in patients with advanced colon cancer. This reduction enables patients to complete a full course of treatment, increasing the likelihood of successful therapy.
Mayo Clinic researchers found that baseline quality of life is a strong predictor of survival in cancer patients, with scores above 83 associated with increased survival time. The study suggests that identifying quality of life deficits can help physicians intervene and improve patient outcomes, potentially extending their length of life.
A study published in Mayo Clinic Proceedings found that men are overrepresented in research on conditions affecting both sexes, while women are underrepresented. The authors recommend standardizing mechanisms for sex-specific reporting and analysis in publications.
Recent research has identified seven LRRK2 gene mutations associated with Parkinson's disease, including a rare mutation that doubles the risk in ethnic Chinese. The findings suggest that genetic influences passed down through generations can significantly increase susceptibility to the disease.
A Mayo-led study found that smoking is associated with an increased risk of developing colorectal tumors lacking DNA repair proteins. Women who smoked were more likely to develop these tumors, which may be due to the loss of function in genes responsible for repairing genetic damage.
Researchers have found that increasing SULF2 expression enhances cancer cell growth and migration, while decreasing it reduces both. The study suggests that blocking SULF2 may lead to an effective treatment for liver cancer and potentially other types of cancer.
A recent study published in Mayo Clinic Proceedings found that 42% of patients who underwent transurethral microwave therapy experienced significant blood pressure surges. Men with enlarged prostates are at higher risk for cardiac events, and monitoring is crucial to manage these risks.
The study found that gut microbiota play a significant role in regulating weight and energy balance. Researchers suggest that manipulating the gut microbiota could be a useful strategy for treating obesity. However, more research is needed to establish the relationship between gut bacteria and obesity.
A Mayo Clinic study found that 82% of retired NFL players under 50 had abnormal artery narrowing and blockages. The researchers emphasize the need for regular cardiovascular screening in football players to prevent serious cardiovascular events.
A new study reveals that people with a normal body mass index (BMI) but high body fat percentage are at risk for metabolic disturbances and heart disease. The researchers found that these individuals had altered blood lipid profiles, high leptin levels, and higher rates of metabolic syndrome.
A study published in the American Journal of Geriatric Cardiology found that established ECG norms for older adults may need to be revised. The research team analyzed over 700 patient readings and discovered that average cutoffs for measuring ECG intervals were greater than current norms, particularly in men.
Researchers found that dopamine can block the growth of new blood vessels in cancer cells by binding to a specific receptor on endothelial progenitor cells. This could lead to a potential treatment for cancer patients, as it slows down cancer progression and reduces tumor growth.
Researchers found that COX-2 expression is a marker for cancer development in some benign breast biopsies, with higher levels associated with increased risk. The study's results may lead to targeted treatments using COX-2 inhibiting agents.
Research highlights the benefits of omega-3 fatty acids for cardiovascular health, particularly among those diagnosed with coronary artery disease. The consumption of fish oil supplements or algae supplements can provide these essential fatty acids.
Researchers found that Asian Indians have higher insulin resistance and mitochondrial function than Northern Europeans, despite being non-obese. This study suggests that urbanization and diet changes may contribute to the increased risk of type 2 diabetes in Asian Indians.
A Mayo Clinic analysis of autopsy results over two decades reveals a long-term decline in coronary disease has ended, with some data suggesting an upward trend. The study's findings are based on the examination of 515 Olmsted County residents who died between 1981 and 2004.
The US donor organ allocation system, MELD score, and its impact on liver transplant outcomes are discussed. Early referral for liver transplant evaluation is found to offer advantages unrelated to waiting time, including early detection and treatment of liver cancer.
Researchers at Mayo Clinic have developed a new technique using two small flexible tubes to stage lung cancer, achieving a 93% accuracy rate in finding malignant lymph nodes. This method is less invasive and more precise than traditional surgical methods, allowing patients to recover the same day.
Antioxidant supplements were found to have no beneficial effects on reducing cancer risk, while beta carotene supplementation was linked to increased risk of smoking-related cancers. The study also provides practical guidelines for workplace drug screening and concludes that nasal spray flu vaccine is a safe and effective way to preven...
Researchers at Mayo Clinic Jacksonville have identified three genes on chromosome 10 associated with Alzheimer's disease. Blood levels of amyloid beta proteins were significantly elevated in asymptomatic young individuals from extended families, indicating a substantial genetic risk factor.
A new Mayo Clinic study identified several gene variations that predict people at high risk for ALS and Parkinson's disease. The researchers found a high-risk prediction factor for ALS (2,000 times greater than average) and for Parkinson's disease (nearly 400 times greater than average).
A new Mayo Clinic study found that removing the entire kidney from younger patients with small kidney tumors may lead to decreased overall survival. In contrast, partial nephrectomy resulted in a 10-year overall survival rate of 93%. The study's findings highlight the importance of considering long-term health consequences for patients...
Physicians must not participate in executions as it contradicts the core concept of ethics in medicine. Lethal injections used in executions raise concerns about pain and human suffering, with experts calling for improved procedures to ensure humane treatment. The Mayo Clinic Proceedings provides a forum for debate on this critical issue.
Researchers designed a technique that uses the body's own cells and a virus to destroy cancer cells, which could lead to a new cancer vaccine. The study shows promising results in treating melanoma, lung cancer, and colorectal cancer by targeting tumor cells in the lymph nodes.
Researchers found that grade 2 and 3 tumors are more common in HER2+ and triple negative cancers, which have a higher risk of growth and relapse. Cancer came back frequently in these subtypes, with a death rate higher in triple negative breast cancer.
A Mayo Clinic program has reduced delays between abnormal mammograms and diagnosis, improving outcomes for women with cancer. The clinic's multidisciplinary breast clinic helped overcome barriers such as lack of transportation and childcare, providing timely care to underserved women.
Two studies from Mayo Clinic found that ER/PR negative breast cancers have the worst overall outcomes when spreading to the brain, resulting in shorter median survival times. Women with triple negative tumors and HER2+ tumors without estrogen or progesterone receptors have poor outcomes due to aggressive brain metastasis.
A new study published by Mayo Clinic researchers found that Herceptin helps women with HER2+ type of breast cancer independent of whether they have extra copies of chromosome 17. The analysis showed significant benefits for patients with polysomy 17, including a disease-free survival rate of 89% after three years of treatment.
New research from the Mayo Clinic suggests that shingles and its complications may have a greater impact on healthy adults than previously thought. The study found that shingles affects at least 1 in every 278 adults each year, with post-herpetic neuralgia being the most common complication, especially among older adults.
A phase II trial of Cybor-D, a combination therapy including cyclophosphamide, bortezomib, and dexamethasone, showed an improved response rate compared to traditional lenalidomide-dexamethasone therapy. The treatment resulted in a rapid initial decline and percentage reduction in M protein levels.
A retrospective study found a link between erythropoiesis-stimulating agents and leukemic transformation in primary myelofibrosis patients. The research confirmed clinical and laboratory variables associated with leukemia development, including specific treatments that increased the risk of leukemic transformation.